# China NMPA Drug Inspection - Changchun Changqing Pharmaceutical Group Co., Ltd. - Chloramphenicol eye drops

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/changchun-changqing-pharmaceutical-group-co-ltd/a1378322-2415-4e44-8a49-5a37bfbb4537/
Source feed: China

> China NMPA drug inspection for Changchun Changqing Pharmaceutical Group Co., Ltd. published March 25, 2020. Drug: Chloramphenicol eye drops. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Changchun Changqing Pharmaceutical Group Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Chloramphenicol eye drops
- Inspection Finding: [Inspection] Related substances, [Content determination]
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/changchun-changqing-pharmaceutical-group-co-ltd/9ffba346-93a2-4547-9930-3675ed3a0459/